When I first set eyes on the new Eversense implantable continuous glucose monitor from Senseonics a few years back, I must admit I was not all that impressed. The idea of having a little stick ...
Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results